Scientific Publications

Molecular sampling of prostate cancer: a dilemma for predicting disease progression.

Publication TypeJournal Article
AuthorsSboner, A., Demichelis F., Calza S., Pawitan Y., Setlur SR, Hoshida Y., Perner S., Adami HO, Fall K., Mucci LA, Kantoff PW, Stampfer M., Andersson SO, Varenhorst E., Johansson JE, Gerstein MB, Golub T. R., Rubin MA, and Andrén O.
AbstractCurrent prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence, we sought to develop a molecular panel for prostate cancer progression by reasoning that molecular profiles might further improve current clinical models.
Year of Publication2010
JournalBMC medical genomics
Volume3
Pages8
Date Published (YYYY/MM/DD)2010/03/16
DOI10.1186/1755-8794-3-8
PubMedhttp://www.ncbi.nlm.nih.gov/pubmed/20233430?dopt=Abstract